Correspondence: The ethics of noninferiority trials.


This brief Correspondence item responds to criticism of non-inferiority trials, and suggests that research to develop new drugs for treatment of drug-sensitive tuberculosis is an appropriate use of such trials.


Lancet (2008) 371 (9616, 15 March) 895

Help us improve GOV.UK

Don’t include personal or financial information, eg your National Insurance number or credit card details.